3 min listen
Targeting Type 1 Diabetes
ratings:
Length:
17 minutes
Released:
Nov 21, 2022
Format:
Podcast episode
Description
Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. Featured guests:Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes. Aaron Kowalski is the President and CEO of JDRF. Felicia Pagliuca is the Disease Area Executive, Type 1 Diabetes, at Vertex PharmaceuticalsDoug Melton leads investigations into treatments for Type 1 Diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetesProduced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Released:
Nov 21, 2022
Format:
Podcast episode
Titles in the series (7)
Introducing, Targeting the Toughest Diseases: Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. The first episode drops October 10th. Subscribe today. by Targeting the Toughest Diseases